Facial hemihypertrophy in a girl with sturge‐weber syndrome: Treatment with oral sirolimus

• DOI: 10.1111/pde.14520
• Publication Date: 2021-01-29T09:45:40Z
• Authors: Aniza Giacaman; José Antonio Sali...; Samuel Navarro No...; Juan Lastra Rodrí...; María Concepción ...; Ana Martín‐Santiago
• Keywords: Sirolimus; Sturge–Weber syndrome; Hemihypertrophy; Girl

In the last few years, use of oral sirolimus has shown promising results in treatment some complex vascular anomalies, and recently, it been used patients with Sturge-Weber syndrome (SWS). We present case an 11-year-old girl diagnosis SWS hemifacial overgrowth treated sirolimus. Throughout eight months follow-up, improvement port-wine birthmark, intraocular pressure, neurocognitive development was noted. The mTOR inhibitors may be useful SWS.